World's First Approved Bispecific ADC Izalontamab Brengitecan Begins Clinical Use at Jiahui
The world's first EGFR×HER3 bispecific antibody-drug conjugate is now available at Jiahui International Cancer Center, offering a new precision option for recurrent or metastatic nasopharyngeal carcinoma.
Read More →
World's First Solid Tumor CAR-T: First Foreign Patient Apheresis Completed at Jiahui
A 59-year-old New Zealand patient becomes the first foreign patient to complete T-cell apheresis for CT041 (Satri-cel), the world's first approved solid tumor CAR-T therapy, at Jiahui International Cancer Center.
Read More →
Dr. Gamaliel VENTO Franco Joins Jiahui Emergency & Family Medicine
A multilingual emergency and family medicine physician with international disaster relief, ECMO, and air/ground medical transport experience joins Jiahui International Hospital.
Read More →
From FIFA to Jiahui: Dr. Ricardo Bastos Brings Elite Knee Care to Shanghai
A Brazilian knee surgeon with 20+ years of experience and eight years at the FIFA Medical Center of Excellence joins Jiahui's orthopedic and sports medicine team.
Read More →
NBI "Eagle Eye" Surgery: A Special Light That Leaves Bladder Cancer Nowhere to Hide
Jiahui's urology team uses NBI narrow-band imaging during bladder tumor surgery to reveal hidden lesions, define tumor margins, and improve surgical precision.
Read More →
New Targeted Therapy for BRAF V600E+ Colorectal Cancer: Encorafenib Now at Jiahui
Encorafenib (Braftovi) plus cetuximab is now available at Jiahui International Cancer Center, offering a precision treatment option for metastatic colorectal cancer with BRAF V600E mutation.
Read More →
New Hope for Platinum-Resistant SCLC: Lurbinectedin Now Available at Jiahui
Lurbinectedin (Zepzelca), a novel transcription-targeted alkylating agent approved in China for metastatic SCLC after platinum progression, is now offered at Jiahui International Cancer Center.
Read More →
The Future of Gastric Cancer Treatment: CLDN18.2 Targeted Therapy & Solid Tumor CAR-T
Zolbetuximab price drops nearly 30% at Jiahui. Satri-cel (CT041), the world's first solid tumor CAR-T, nears approval. Both targeting CLDN18.2 — now available at Jiahui International Cancer Center.
Read More →
From Palliative Care to a Second Chance at Life: A Pakistani Patient's CAR-T Journey to China
Read how Muhammad came to Jiahui after relapsing post-transplant, and found hope through CAR-T therapy — a story of cross-border care, compassion, and healing.
Read More →
From "Darkest Hour" to "Unexpected Connection": An American Couple's First Trip to China
When a seventy-year-old American couple's dream trip to China took an unexpected turn, Jiahui's orthopedic team stepped in — delivering internationally benchmarked surgery and a reason to return.
Read More →
When Parkinson's Meets a Surgical Emergency: How Jiahui's MDT Team Saved a 75-Year-Old Patient
35 years of Parkinson's disease. A sudden duodenal perforation with liver abscess. Nine departments. One patient. Read how Jiahui's MDT team turned an impossible case into a story of recovery.
Read More →
One Sneeze, Near Paralysis: A Singaporean Woman's 72-Hour Spine Emergency in Shanghai
A single sneeze triggered a massive L5-S1 disc herniation that nearly paralyzed a young expat. How Jiahui's spine team performed minimally invasive endoscopic discectomy through a sub-1cm incision — and had her walking within 24 hours.
Read More →
A New Era for Alzheimer's: Jiahui Launches First Donanemab Treatment in Shanghai
From symptom relief to disease modification — Jiahui Neurology Center administers its first Donanemab infusion, a monoclonal antibody that clears amyloid plaques from the brain. Early patients can extend independent living by over 3 years.
Read More →
"Scarless" Surgery: Jiahui HIFU Technology for Uterine Fibroids & Adenomyosis
When ultrasound becomes an invisible scalpel. Jiahui Gynecology introduces non-invasive HIFU technology — no incisions, no scars. Malaysian OB/GYN delegation visits for international knowledge exchange.
Read More →